The latest breakthroughs in neuroendocrine tumour (NET) research took centre stage at the ENETS 2024 Conference, where experts from around the globe convened to share insights, present findings, and discuss the most promising avenues for research into treatment and management of this complex disease.
Hosted by the European Neuroendocrine Tumour Society (ENETS), the conference featured a diverse array of presentations, workshops, and interactive sessions spanning various aspects of NETs, including diagnosis, therapy, and translational research.
Moreover, significant strides were made in the realm of diagnostic techniques and imaging modalities for NETs. Cutting-edge imaging technologies, such as positron emission tomography (PET) and advanced radiological imaging, were showcased, providing clinicians with enhanced tools for accurate staging and monitoring of NET patients.
The conference also provided a platform for the exchange of clinical insights and best practices in the management of NETs. Experts shared their experiences with emerging treatment modalities, including peptide receptor radionuclide therapy (PRRT), targeted therapies, and immunotherapies, genomics, familial NETs highlighting both successes and challenges in delivering personalised care to patients with NETs.
In addition to scientific presentations, ENETS 2024 featured interactive workshops and panel discussions aimed at addressing the multidisciplinary nature of NET care. Clinicians, researchers, nurses, and patient advocates collaborated to explore innovative approaches to patient management and guidelines, symptom control, and supportive care strategies, emphasising the importance of a holistic approach to treating NETs.
The conference also served as a forum for networking and collaboration among stakeholders in the field of neuroendocrine oncology. Participants had the opportunity to forge new partnerships, foster collaborations, and engage in discussions aimed at improving outcomes for patients with NETs.
The INCA / ENETS Symposium highlighted the work being done internationally in a joint strategy of patient advocates and ENETs experts developing and delivery education programs to primary care physicians and other healthcare professionals to increase awareness, earlier detection, knowledge and management of NETs. Speakers in this session were Prof Dermot O’Toole (leading consultant of expert team – Dublin), Teodora Kolarova (INCA Executive Director), Meredith Cummins (NECA CEO), Prof Martyn Caplin (leading consultant of expert team – London) and Mark McDonnell (Past President of INCA).
As the ENETS 2024 Conference drew to a close, participants left inspired by the wealth of knowledge shared and the collaborative spirit that permeated the event. Armed with new insights and innovative approaches, the global community of neuroendocrine tumour specialists is poised to continue making strides in understanding, diagnosing, and treating this challenging disease.
For more information about the ENETS 2024 Conference and updates on neuroendocrine tumour research, visit ENETS Conference website.
